The biopharmaceutical sector experiences a volatile rebound, with Konruns hitting the daily limit
The biopharmaceutical sector experienced a volatile rebound, with Konruns hitting the limit up, followed by gains in Baiao Tai, Saiseng Pharmaceutical, Hite Bio, Eddie Pharmaceuticals, Saifen Technology, Junshi Biosciences, and others
